Full Length Research Paper
References
|
Abdel-ilah L, Veljovi? E, Gurbeta L, Badnjevi? A (2017). Applications of QSAR Study in Drug Design. International Journal of Engineering Research and Technology 6(06):582-587. |
|
|
Alberga D, Trisciuzzi D, Montaruli M, Leonetti F, Mangiatordi GF, Nicolotti O (2019). A New Approach for Drug Target and Bioactivity Prediction: The Multifingerprint Similarity Search Algorithm (MuSSeL). Journal of Chemical Information and Modeling 59(1):586-596. |
|
|
Arefin A, Hossen S, Islam T, Islam A, Biswas P, Nu A (2021). Target specificity of selective bioactive compounds in blocking α-dystroglycan receptor to suppress Lassa virus infection: an in silico approach. Free full text Target specificity of selective bioactive compounds in blocking α- dystroglycan receptor to suppress Lassa virus infection: an in silico approach. Journal of biomedical research 35(6):459. |
|
|
Attanasi ED, Coburn TC (2023). Random Forest. In: Daya Sagar, B.S., Cheng, Q., McKinley, J., Agterberg, F. (eds) Encyclopedia of Mathematical Geosciences. Encyclopedia of Earth Sciences Series. Springer, Cham. |
|
|
Bosc N, Felix E, Arcila R, Mendez D, Saunders MR, Green DVS, Ochoada J, Shelat AA, Martin EJ, Iyer P, Engkvist O, Verras A, Duffy J, Burrows J, Gardner JMF, Leach AR (2021). MAIP: a web service for predicting blood ? stage malaria inhibitors. Journal of Cheminformatics pp. 1-14. |
|
|
Chakravarti SK, Alla SRM (2019). Descriptor Free QSAR Modeling Using Deep Learning with Long Short-Term Memory Neural Networks. Frontiers in Artificial Intelligence 2:1-18. |
|
|
Creative Biolabs (2024). Recombinant Lassa IV Virus-like Particles (LASV IV VLPs). Available at: |
|
|
Hasan R, Alsaiari AA, Fakhurji BZ, Habibur M, Molla R, Asseri AH, Sumon AA, Park MN, Ahammad F, Kim B (2022). Application of Mathematical Modeling and Computational tools in the modern drug design and development process. Molecules 27(13):4169. |
|
|
Id APS, Duvignaud A, Jaspard M, Malvy D, Carroll M, Tarning J, Olliaro PL, Horby PW (2022). Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing. PLoS Neglected Tropical Diseases pp. 1-18. |
|
|
James O (2020). Modelling and optimal control analysis of Lassa fever disease. Informatics in Medicine Unlocked 20:100419. |
|
|
Kikiowo B (2021). Molecular Interaction and Inhibitory Activity of Dandelion's Compounds on Nucleoprotein: A Therapeutic Intervention in Lassa Fever. Biointerface Research in Applied Chemistry 11(5):12573-12583. |
|
|
Klitting R, Kafetzopoulou LE, Thiery W, Dudas G, Gryseels S, Kotamarthi A, Vrancken B, Gangavarapu K, Momoh M, Sandi JD, Goba A, Alhasan F, Grant DS, Garry RF, Smither AR, Zeller M, Pauthner MG, Mcgraw M (2021). Predicting the evolution of Lassa Virus endemic area and population at risk over the next decades. Nature Communications, pp. 1-17. |
|
|
Kwon S, Bae H, Jo J, Yoon S (2019). Comprehensive ensemble in QSAR prediction for drug discovery. BMC Bioinformatics pp. 1-12. |
|
|
Minari J, Agho E, Adebiyi F, Rotimi O, Sholaja B, Adejumo J (2021). Molecular Docking and Identification of Candidate Blockers for Endonuclease Domain of Lassa Virus Polymerase as Potential Drugs. Journal of Applied Sciences and Environmental Management 25(11):1899-1907. |
|
|
Makolo AU, Ajiboye F (2023). Prediction of Genomic Signature of Ngs Sequences and Comparative Drug-Likeness. American Scientific Research Journal for Engineering, Technology and Sciences 90(1):573-589. |
|
|
Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V (2010). Advances in computational methods to predict the biological activity of compounds. Expert Opinion on Drug Discovery 5(7):633-654. |
|
|
Oloniniyi OK, Unigwe US, Okada S, Kimura M, Koyano S, Miyazaki Y, Yasuda J. (2016). Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria Author summary. |
|
|
Simeon S, Anuwongcharoen N, Shoombuatong W (2016). Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking. |
|
|
Tan E, Sze C, Chin H, Feng Z, Lim S, Ng SK (2021). HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors. Frontiers in Bioengineering and Biotechnology 9:1-9. |
|
|
Ursu O, Rayan A, Goldblum A, Oprea T (2011). Understanding drug? likeness. Wiley Interdisciplinary Reviews: Computational Molecular Science. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
